THOMPSON INVESTMENT MANAGEMENT, INC. - ADICET BIO INC ownership

ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 87 filers reported holding ADICET BIO INC in Q2 2024. The put-call ratio across all filers is 8.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
THOMPSON INVESTMENT MANAGEMENT, INC. ownership history of ADICET BIO INC
ValueSharesWeighting
Q2 2024$97
-48.4%
800.0%0.00%
Q1 2024$188
+24.5%
800.0%0.00%
Q4 2023$151
+37.3%
800.0%0.00%
Q3 2023$110
-43.3%
800.0%0.00%
Q2 2023$194
-57.9%
800.0%0.00%
Q1 2023$461800.00%
Other shareholders
ADICET BIO INC shareholders Q2 2024
NameSharesValueWeighting ↓
Abingworth LLP 1,615,385$16,574,0005.12%
Consonance Capital Management LP 1,025,405$10,551,0001.27%
Ally Bridge Group (NY) LLC 425,000$4,373,0001.09%
DAFNA Capital Management LLC 376,281$3,872,0000.81%
Johnson & Johnson Innovation - JJDC, Inc. 728,944$7,501,0000.77%
Orbimed Advisors 7,232,856$74,426,0000.75%
Avidity Partners Management LP 2,250,500$23,158,0000.63%
Altium Capital Management LP 142,289$1,464,0000.34%
VR Adviser, LLC 183,702$1,890,0000.23%
KINGDON CAPITAL MANAGEMENT, L.L.C. 115,000$1,183,0000.14%
View complete list of ADICET BIO INC shareholders